Objectives Vaccination against COVID-19 emerges as an effective strategy for combating
the pandemic. While many of our patients with rheumatic diseases (RD) wonder whether it is …

Introduction To investigate the vaccination rate, reported side effects, and patient concerns
for COVID‐19 vaccination in patients with rheumatic diseases. Methods A multicentre cross …

Objectives To evaluate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine acceptance among patients with rheumatic diseases (RMD). Methods All …

SARS-CoV-2 vaccines appear to be the most promising strategy for fighting the virus and
protecting also those who might be at higher risk of severe COVID-19, such as patients with …

Vaccination is an important and effective tool to prevent infections in the general population,
as well as in patients with autoimmune and inflammatory rheumatic diseases. It has been …

Before widespread vaccination programmes, potential side-effects and flares after COVID-
19 vaccination were frequent reasons for vaccine hesitancy among people with rheumatic …

Aim The frequency of vaccine refusal and hesitation, which is associated with many factors,
is increasing worldwide. The purpose of this study is to estimate the frequency of vaccine …

Background People with chronic conditions such as cancer, kidney disease, lung disease,
diabetes, dementia, obesity, and heart conditions are at elevated risk of developing severe …

Patients with a systemic autoimmune rheumatic disease (AIRD) are vulnerable to SARS Cov-
2 infection. Vaccination against this infection can prevent the patients from developing …

Introduction While discussions on the effectiveness of COVID‐19 vaccines continue,
healthcare professionals' attitudes and their growing fear and anxiety during the pandemic …